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Abstract
Understanding the systems-level behaviours of the immune system re-
quires profiling many parameters of its constituents as well as identifying
environmental factors influencing the time evolution of immune response.
Recent advances in technologies enable multiple cellular components to be
measured simultaneously at an unprecedented scale and resolution across
many individuals, and the resulting data could be used to meet this goal.
Such data allows studying the immune system as a whole enabling a holis-
tic approach. The goal here is to analyze such high-dimensional data by
examining the measured parameters interdependence in order to infer the
emergent behaviours of the immune system. This thesis involves different
techniques to analyze various datasets in order to reveal new insights into
mechanisms of human immunity of relevance to environmental exposures.
This dissertation presents results from four studies.
I. The human immune variation is continuous, rather than described by
discrete groups of individuals with similar immune cell populations.
How can collective states of many immune system components de-
scribe immune variation across individuals? Using partial least squares
method, we derived a set of aggregate immune cell population frequen-
cies that define an individual’s immunotype, and robustly predict di-
verse functional responses to cytokine stimulations. In immunotype
space, individuals of younger age are similar to one another than older
individuals are. Cytomegalovirus seropositivity induces a shift of one’s
immunotype towards a more aged immunotype.
II. Mothers transfer antibodies but we don’t know what their composi-
tion looks like. What are the transferred maternal antibodies? How
large is the repertoire of maternal antibodies, their specificities, and
duration after birth? Using VirScan method, we assayed around 107
antibody-peptide interactions in mother-child dyads. The repertoire
of antiviral maternal antibodies target between 5-10 different viruses,
and the transferred antibodies mirrors those found in the mothers. Al-
though IgG transfer happen principally during the final trimester, very
preterm (<30 weeks of gestation) and term (>37 weeks of gestation)
children receive a similar repertoire. However, the concentrations of
antibodies at birth are lower in preterm than in term children, and
determine how long the conferred immunity lasts for.
III. Newborns adapt to living outside the womb, suddenly exposed to new
bacteria and viruses, which leads to a rapid biological change of human
vnewborn immune system. Can phenotypic variants of developing hu-
man newborn lymphocyte be explained regarding of trade-offs between
specialist and generalist phenotypes? In immune system, individual
cells face a dilemma. No single cell can be optimally suited for all
possible tasks, and therefore cells specialize to perform specific tasks.
For example, in the human immune system, cytotoxic lymphocyte kills
virus-infected cells, and B-lymphocytes produce antibodies, etc. Us-
ing Pareto archetype analysis, we learned geometrical shapes of protein
expression space from longitudinal human newborn lymphocyte data.
Single B cells are arranged in a triangle, while CD4+ T cells are best
represented by pentahedron. The vertices of these shapes are extreme
protein expression profiles optimal for tasks and correspond to major
cell subsets. Cells lie along a continuum of expression inside polytope.
In triangle B cells, a 1D continuum of states describes cells special-
ization pattern to tasks and suggests pseudo-time trajectories in the
developmental path of the newborn B cells.
IV. The variation of transcriptional responses to microbial stimulants is
large among primary immunodeficiency disorder (PID) patients, and
little in healthy individuals. How can functional defects in PID patients
be inferred from transcriptional variation of human immune responses
to bacterial and viral challenges? We deduced a collective set of genes
that can predict variation of transcriptional responses to stimulant anti-
gens in PID patients. Lastly, we identified gene variants associated with
the differences in transcriptional responses between PID patients and
healthy individuals allowing understanding immune functional defects
in patients.
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Chapter 1
Introduction
1.1 Basic immunology
Few years after Charles Darwin’s theory on diversity and natural selection
was published in 1859, infectious diseases were discovered, and the first pos-
tulate of immune system emerged as an active force of the human body
defense against pathogens, and since then the theory has helped researchers
in studying how our immune defenses arose [1, 2].
In subsequent years, immunologists realized that our immune defense de-
pends on a system of diversity with many specialized cells to tasks. The
immune system is commonly distinguished in two categories according to
their defense mechanisms: innate immunity refers to a non-specific defense
mechanism with an immediate response. The discovery of B and T-cell re-
ceptors [3, 4] that recognize proteins of pathogens has led to a new form
of immunity, adaptive immunity, which refers to antigen-specific immune
response. Ehrlich and Metchnikoff pioneered two competing defense mech-
anisms consisting of this latter: the humoral system of antibodies and cell-
mediated immunity from white blood cells, for which they received the Nobel
prize in 1908.
It took a half-century to gain a comprehensive understanding of achieving
diversification of immune responses to all existing pathogens or molecules.
Burnet suggested that lymphocytes are key evolutionary players being se-
lected in the body to undergo a process called clonal selection [5]. Later in
the 1970s, the clonal selection theory was complemented by a process called
somatic Variable, Diversity and Joining (VDJ) recombination [6], where
Tonegawa demonstrated how maturing B cells could produce a vast array of
antibodies. According to these processes, developing lymphocytes rearrange
gene segments and result in a highly diverse repertoire of immunoglobulins
(Igs) and T-cell receptors found in B-cells and T-cells, respectively, and then
1
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maintained in the body as an immune memory. However, it was until the
year 1990 after identifying Major Histocompatibility Complex (MHC)-locus
genes [7] that the whole process was fully understood.
From a functional point of view, in the late 19th century, immunity emerged
as a host defense. Immune functions were associated with wound healing [8],
pain signaling [9], clearance of cancer [10], and many more [11]. Recently,
studies have identified new immune components such as dendritic [12] and
Natural Killer (NK) [13] cell lineages, and T helper cell subsets [14]. Such
developments in defining molecular and cellular networks have tremendously
advanced our understanding of defense mechanisms of immune function.
1.2 Motivation
It is heuristically understood how pathogenic and non-pathogenic signals
modulate the immune response of the innate and adaptive immune sys-
tem. Apart from discriminating between self- versus non/altered-self, the
immune system maintains homeostasis by balancing between mounting an
appropriate response to some stimuli while remaining unresponsive to others,
for example, microbes that are crucial to development, nutrition, and more.
This is only achieved through a network of interactions [5, 15] between many
specialized immune cells and soluble mediators.
1.3 Scope and outline of the dissertation
In this thesis, a systems approach is adopted to study human immune sys-
tem behaviors. This approach does not depend on formulating any specific
research hypothesis. Otherwise, it would require drawing on ideas and intu-
itions from our knowledge of the immune system that comes from decades
of work on mice [16]. As we will see below, this could be limiting given
remarkable differences between mice and humans. In general, our intuition
of how the human immune system works is based on observed behaviours.
To understand these, immunological observables, e.g., cell frequencies, im-
mune phenotypes, and perturbed genes expressions, are explained in a given
condition or over time. Moreover, different contexts (health against diseases,
stimulated against non-stimulated) are considered for comparison purposes.
This thesis is organized as follows. It consists of seven chapters. The first
chapter introduces briefly basic immunology with a special focus on the im-
mune functions. The second chapter describes the concepts of systems im-
munology as well as technological advances allowing this. In chapter 3, an
introduction to the development of the human immune system related to
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the present thesis is briefly given. In chapter 4, the goals of this thesis are
described with respect to the presented results. The fifth chapter describes
the experimental work leading to generating data and computational meth-
ods to analyze the data. Chapter 6 summarizes the results presented in the
constituent papers. Finally, conclusions and future perspectives are given in
Chapter 7.
Chapter 2
Systems Immunology
2.1 Introduction
The immune system is an intricate network of many cells and molecules
interacting to generate an immune response against infection and maintain
self-tolerance to host tissues [17–24]. Such a network of interactions is depen-
dent upon changes in immune cell composition over time. Many specialized
cell types execute distinct immune functions. They exist in a continuum of
development and communicate and modulate each other while preventing
autoimmune conditions. During an immune response, changes in immune
cell frequencies occur, and this could result in an altered balance between
activation and inhibition that causes a complete state-of-shift of the entire
immune system.
2.2 Why systems-level view of the human immune
system?
2.2.1 Emergent properties of the immune system
Despite this intricate network of interactions between immune components,
reductionist experiments have dominated immunology and hindered the study
of signaling in the immune system.
From a behavioural perspective, the immune system evolved to mediate a
coordinated set of defensive functions via cell-cell interactions and soluble
mediators -cytokines- that would optimize successful adaptation [25–27] and
survival. The immune system can
• Recognize antigens and induce immune responses
• Retain memories of previously encountered antigens
4
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• Make decision on the best strategy to cope with pathogens
For this latter, like any sensory system, the immune system senses and rec-
ognizes molecules of variable compositions, properties, and sources [28, 29].
With this sensing capability, the immune system is not only able to respond
or sustain interaction but also to simultaneously deal with several pathogens
at the same time without conflicting with maintaining interactions with both
microbes and host. This multitasking ability of the immune system requires
the simultaneous recall of multiple patterns for reaching homeostasis.
In summary, the immune system performs tasks as a decentralized system.
The collective actions of all the different cell populations determine the emer-
gent behaviours of a whole network. However, such behaviours cannot be
predicted from analyses of the individual cell populations one by one [30–33].
2.2.2 Applications of basic immunology in clinical problems
The human immune system is actively involved in combating infections and
immune system dysfunctions are involved in immunodeficiency disorders and
autoimmunity. Moreover, diseases like cancer [34], cardiac diseases, degen-
erative diseases [35], psychiatric diseases [36], and diabetes are not directly
immune related but have a basis of immunological mechanisms [37].
With these conditions, pharmacological control targeting at modulating the
host immune response instead of the causative agent itself may be useful
in treating diseases. Immunomodulatory treatments such as hematopoietic
stem cell transplantation [38], monoclonal antibodies [39], immunosuppres-
sants [40], inflammatory disease [41], and checkpoint therapy [42–45] have
contributed significantly for this purpose. While these treatments have been
useful, however, responses to these therapies are different across individual
patients with unexpected side effects [46, 47]. This exemplifies inadequacy in
the current understanding of the human immune system and importance of
interindividual variability, indicating its theoretical basis should be updated
before being applied in the clinics. Our current knowledge of the immune
system has been inferred from extensive studies on a mouse model of com-
plex human disease. For example, type 1 diabetes has been cured multiple
times in mice [48] and not in humans.
Several reasons tempting to explain this unsuccessful application of mouse
model of diseases to the clinical conditions have been speculated. These
include unavoidable compromises of many disease induced-approaches [49],
phenotypic imbalance of immune components between humans and mice [50]
explained by an evolutionary distance, and the overall difference in lifespan
between mice and humans.
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Such unsuccessful applications have stimulated a shift from mouse model
studies to human studies [51, 52], to better understand human conditions
and stimulate progress in developing novel therapies. Herein, one could
perform systems analysis of blood that includes sampling white blood cells
(lymphocytes) and cytokines to probe communications between cells and
tissues. Continuous discovery of various surface markers and cytokines fa-
cilitates this. Because of that, immunological health could be defined first
and serves not only as metrics to the physicians but also in investigating
mechanisms of diseases per se [16, 51].
2.3 Technological advances allowing human system-
immunology
Cellular functions and phenotypes depend on a coordinated behavior of many
interacting intra-cellular components: genes or proteins and their products,
and not on a single gene or protein. These cellular components can be
partitioned into modules [53] where they interact with each other, and their
combined performances determine the function and states of a cell [54]. With
this modular approach [54], the number of degree of freedom that must be
considered has been drastically reduced. As a result, cellular characteriza-
tion requires multiple parameters to be measured simultaneously.
Besides, cells are frequently reacting to different stimuli by changing their
phenotype due to induced changes in expression patterns of proteins or genes.
Moreover, cells from the same tissue can be inherently heterogeneous in
space. Identifying the different types of cells within a differentiated cell pop-
ulation is not possible from one or two of cellular parameters. As a rule
of thumb, to understand system-wide cellular function in various contexts,
one needs to profile multiple cellular parameters and with single-cell resolu-
tion [55, 56].
As a result, the key goals of biology have then been relating to the structure
of genes/protein networks with the functions that they perform. In recent
years, an effort has shifted from understanding individual genes to under-
standing all genes or proteins in determining cell functions. Great strides
were made in advancing novel technologies, so-called omics-technologies (Pro-
teomics, transcriptomics, and genomics). The introduced technologies have
enhanced the throughput, scalability, and the amount of data generated from
them. They allowed taking a holistic approach to studying the immune sys-
tem.
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Technological advances have strived to capture cellular components’ inter-
actions at different length scales. In immunology, a conventional technology
for such cellular analyses is flow cytometry. This technology allows ana-
lyzing over 200,000 cells [57] for 15 [58, 59] parameters using fluorescently-
labeled antibodies. However, given the limited light spectra, and the already
overlapping emission signals, a limited number of different cell populations
can be distinguished and characterized phenotypically and functionally. To
overcome this limitation, Mass cytometry or Cytometry by time-of-flight
(CyTOFTM, Fluidigm Inc) has been developed (detailed description is given
in the section below) [60]. Mass cytometry is an antibody-based technology
allowing 50 parameters to be quantified simultaneously. As a result of this,
we are now able to study phenotypes [61] and function states [62] of all im-
mune cell populations present in human blood. Applications have been ex-
tended recently to the studies of messenger Ribonucleic Acid (mRNA) [63].
These technologies have focused on capturing the complexity of intercellular
signaling comprehensively at the protein level. They provide broad cover-
age across all cell types in the blood. Clusters of functionally similar cells
are prone to overlap in their protein expression profiles rather than being
distinct [16, 63]. For an in-depth characterization of cellular interactions,
system-wide transcriptional approaches have given more insights into well-
defined and rare immune cell populations and their intracellular communi-
cation networks [30]. For example, next-generation sequencing has paved a
way in studying gene regulatory circuits in immune cells [64], immune cell
type heterogeneity [65], and identifying cell fate and clonality of immune
cells and their specificity [66, 67].
Depending on a given condition, disease, or stimulation, these high-dimensional
technologies offer analyses of overall immune system composition and enable
a subsequent analysis of interdependencies between immune components.
On the contrary, an individual’s immune system encounters many pathogens
during life. As a result, understanding an individual’s exposome, i.e., collec-
tive environmental exposure, is essential. Also, here novel technologies have
begun to provide some additional information. For example, the application
of next-generation sequencing to measure the microbial composition of fecal,
skin, tissue, and blood samples are increasingly done [68]. Also, by analyzing
serology in high-throughput, an individual’s infectious disease history can be
investigated. For example, the VirScan assay [69] measures IgG antibodies
to 94,000 peptides representing the entire proteomes of 1000 viral strains
known to infect human cells. This method has been used in our projects and
will be described in more detail below.
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2.4 Advances in data analysis enabling systems im-
munology
In today’s high-dimension biological data deluge, one needs storage and a
new mathematical framework that is both solvable and computationally ef-
ficient. The nature of raw data from the technologies described above is
explained in terms of probes estimates. It contains a lot of noise and techni-
cal artifacts given dynamical range of increased number of parameters. As
a result, the preprocessing of data is often performed before making any
biological interpretation. Also, unlike traditional statistics that deal with a
small number of parameters with very little noise, retaining sufficient infor-
mation from noisy biological data is much more challenging [63, 70].
To deconvolve a cell mixture in a tissue, advances in technology have fo-
cused on measuring multiple cellular parameters in a single cell, e.g., mass
cytometry and single-cell transcriptome sequencing. Several tools based on
unsupervised clustering algorithms have been developed [71–73]. For ex-
ample, Citrus [74] has been used to delineate cellular subpopulations that
display condition-specific behavior between patients and healthy controls.
However, given the random realization of high dimensional noise, classical
clustering algorithms utilizing dimensionality reduction are prone to discov-
ering (illusory) structures that do not exist in the raw data.
However, data-driven clustering techniques assume that cells cluster in dis-
crete groups; therefore, they may inaccurately model some biological pro-
cesses given a discrete nature of this approach. An example is cell differ-
entiation, where a cell is undergoing continuous changes from stem cell to
a mature phenotype. To circumvent this limitation, tools are developed
to learn developmental trajectories from single-cell data [75–77] and have
identified transitional cell states and mechanisms that govern their differen-
tiation [78].
From a dynamical point of view, the immune response evolves, and the de-
scription of this time evolution is of great interest in systems immunology.
The immune system would develop into dynamic regimes that remain qual-
itatively unchanged given a finite range of parameters, e.g., aging. Do such
dynamic regimes exist in the immune system? How could one induce transi-
tion among the different dynamical regimes? With the systems immunology
approach, there is a slowly growing number of studies that have started to
respond to these. For example, variations in immune systems of healthy
individuals have shown that the immune cell frequencies of young, identical
twins (< 20 years) correlated strongly, while older twins (> 60 years) did not,
suggesting a cumulative influence from environmental factors over time that
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shape immune system [79]. Similarly, immune cell frequencies of older indi-
viduals as a group are more heterogeneous than younger individuals. Human
cytomegalovirus infections make an immune phenotype look older irrespec-
tive of the actual age of the individual in the immune space [80]. Also, from
a theoretical point of view, Agliari et al advised a model describing different
immune regimes for B and T-cell interactions explaining the ability of the
immune system to respond simultaneously to multiple distinct antigens by
combining techniques from statistical mechanics and graph theory [32].
Finally, algorithms for dimensionality reduction are used for visualization
purposes or downstream analysis. They capture different aspects of the
dataset and differ on how they preserve the structure of the raw data. The
following are commonly used for dimensionality reduction of mass cytom-
etry single-cell data. Principal Component Analysis (PCA) [81] captures
40 − 50% of the variance on the top three principal components. Since it
assumes a linear distance between cells, it misrepresents cells existing on
non-linear distance. On the other hand, t-distributed Stochastic Neighbor
Embedding (t-SNE) [73, 82] provides an alternative. t-distribution focuses
on preserving local neighborhoods and usually is successful at keeping non-
linear relationships between markers better than linear approximation meth-
ods such as PCA. In contrast, t-SNE does not maintain the global structure
of the data, causing some limitations in its interpretation.
2.5 From reductionist to holistic view of immunol-
ogy
Current advances in technologies provide high-throughput measurements
and analysis of multiple parameters simultaneously. With this in mind, re-
searchers have started to ask questions pertaining not to a single cell type
or a single protein but to many cell populations and serum proteins simulta-
neously aiming to understand collective behavior and patterns of the human
immune components. This allowed tackling questions like inter-individual
differences dictated by genetic diversity and environmental exposures in hu-
mans, which were otherwise unattainable using conventional methods [83].
In a single time point, perturbations are applied to the immune system, and
simultaneous measurements of initial and resulting states are performed to
quantify immune response [84]. Over time or in multiple time points, tempo-
ral aspects of the complexity of immune system behaviors can be captured.
Moreover, humans are subject to several perturbations throughout their life-
times and infections. This has led researchers to explore an individual’s
infection history.
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These technologies enabled interrogating the immune system in the systems-
level setting. A couple of studies have shown a variation of the immune
cell composition in the blood of individuals, which measures the dispari-
ties between individuals’ responses to the same immunological stimulation.
Changes in the cell populations’ phenotypes are compared against the base-
line in these cell populations over time, within an individual, and or between
individuals. Human immune cell frequencies and serum protein levels are
initially found to be stable over a period of time for a given individual and
result in highly variable between healthy individuals, at least in healthy
adults [85–87].
The variation within individuals is due to heritable factors and an unexpected
dominance of non-heritable factors influences from infections, vaccines, nu-
tritional factors, and the microbiome, explaining most of the variation for
77% of all immune cell frequencies, functions, and serum protein measure-
ments [79]. Similarly, Patin et al. have demonstrated that heritable factors
influenced the parameters of innate cells more than adaptive cells. The en-
vironmental exposures analyzed included smoking, age, and latent infection
with cytomegalovirus, and those explained more of the variance in adap-
tive than innate cells [88]. Adaptive changes in the immune system induced
by environmental influences are explained by increased epigenetic variations
with age [89].
These are few examples exemplifying the use of a holistic approach in un-
derstanding immune system phenotype and function. This paradigm shift
focusing on human studies is believed to extend our understanding of the
immune system that could be more easily translated to the clinics [16, 83].
Chapter 3
Development of the human
immune system
Heterogeneous immune phenotypes in adults are widely accepted and are
highly explained as an accumulation of non-genetic factors’ influence. Little
is known on the identity of these factors and when they exert this influ-
ence. As a start, one should note the phenotypical and functional differences
between the fetal and adult immune systems. The former emerges from a
relatively sterile environment, in utero, while being prepared to fight against
enormous pathogens (bacteria, fungi, and virus) directly after birth [90, 91].
Given the differences in exposure to antigens and environmental stimuli for
infants and adults, examining disease susceptibility both at the early life
and later in life demands an understanding of the heritability of immune
responses and the variability of the responses [92, 93]. Understanding the
early life immune response could lead to identify, prevent, and treat early
life infectious diseases.
3.1 Immune cell composition of blood throughout
development in early life
Fetal hematopoiesis takes place in the yolk sac and moves to the liver and
other tissues during gestation, where both lymphoid and myeloid cells arise [94].
The earliest tissue-resident macrophages appeared at gestational week four,
and the most initial T cells identified at ten weeks of gestation [95]. The
progenitors resided in the fetal liver at 6 to 22 weeks of gestation, and the
production of the cell moved to the bone marrow until birth [94, 95]. Our
knowledge of the ontogeny of the fetal immune system comes from studies
in mice [96].
The study of immune system development in human’s fetus is naturally
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proven challenging to carry on, and more is known about development from
birth to adulthood. With high dimensional single-cell technologies, researchers
have studied counts and frequencies of white blood cells after birth. In many
studies, some common patterns are observed and suggest a robust develop-
mental process. For example, i) white blood cell count decreases from birth
until adulthood where it reaches a stable number [97, 98], ii) the ratio be-
tween naïve and memory T-cell decreases continuously [97–100], and the
CD4:CD8 ratio decreases from birth to adulthood [97–99, 101–103].
3.2 Passive immunity by maternal antibodies in hu-
man newborns
Antibodies exist in different isotypes such as IgA, IgD, IgE, IgG, and IgM.
During pregnancy, maternal antibodies (IgG) are transferred across the pla-
centa to the fetus [104, 105] by the neonatal Fc receptor (FcRn), and other
possible unidentified receptors [106]. Several factors, such as IgG subclass [107,
108], antigen specificity[109, 110] and chronic maternal infections [111] have
been proposed to influence the rate of IgG transfer. Antibody transfer is
believed to occur after 28 weeks of gestation [104, 112]. Therefore, preterm
birth is a determinant factor for the transfer of maternal antibodies and
may limit the transport of IgG [113–115]. Such a lack of passive immunity
has been suggested as a reason for the higher risk of infectious diseases in
preterm children. The transferred antibodies provide passive immunity until
newborn IgG starts to produce around 15 weeks after birth [116].
Many studies have focused on individual viruses [117–120] by mostly using
the Enzyme-linked Immunosorbent Assay (ELISA) method, which is limited
in throughput and coverage. With recent technological advances, we have
started to ask questions like: what are the transferred maternal antiviral
antibodies? How large is the repertoire of transferred maternal antiviral
antibodies, their specificities, and duration after birth? Answering these
questions would imply understanding infectious disease susceptibility, and
vaccine scheduling in newborn children.
3.3 Environmental influences on the Immune sys-
tem
Among factors shaping the immune system include heritable and non-heritable.
This latter has been shown to influence the immune system in healthy adults
largely [87, 121, 122]. In early life, non-genetic factors accepted to shape
the human immune phenotype are identified and include mode of delivery,
medication, diet, and infections [123, 124]. There is evidence showing that
environmental exposures during the first days of life can predispose for nor-
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mal immune development [125, 126].
For that, several studies have shown how these non-genetic factors influence
the immune phenotype in newborn children. One of the factors that are
well studied is the mode of delivery: vaginal delivery due to the increase
in stress hormone levels during labor corresponds to higher levels of several
cytokines [127–130]. At the same time, caesarian sections have been related
to higher granulocyte and leukocyte in cord blood [127, 128, 131]. Other en-
vironmental factors that are associated with the immune phenotype include
but not limited to antigen exposure [132, 133] , breastfeeding [134–137], viral
infections [134], and maternal smoking [138].
Lastly, the effects of non-genetic factors on the immune system are displayed
through the latent modulation of the gut microbiota [139, 140]. The bacteria
exposures of the baby at birth initiate the microbiota, which develops and
stabilizes years later in life [141]. Similarly, the immune system and the gut
microbiota composition are both partially shaped by host genetics [142–144].
Recently, studies have shown a relationship between gut microbiota compo-
sition and environmental factors. The microbiota composition is influenced
by some perinatal factors such as mode of delivery [145, 146], diet [145–148],
and antibiotics [145–148]. There is increasing evidence showing the associ-
ation not only between the microbiota and the immune phenotype but also
the development of immune-related disease [149, 150].
Chapter 4
Aims
The overarching aim of this thesis is to understand the natural development
of the human immune system with a focus on studying how environmental
factors shape it. To do this, we used systems-level analyses to investigate the
immunity from different cohorts consisting of very preterm children to old
adults with various environmental exposures. From here, immune system
behaviors expressed in immunological observables such as cell frequencies,
immune phenotypes, and perturbed genes expressions give insights into how
the immune system works.
The specific aims of each study are:
Paper I. To investigate whether differences in immune response could be
explained by variation in immune cell compositions across individuals.
Paper II. Assess antiviral antibodies in preterm and term mother-child
pairs, their specificities, and duration after birth.
Paper III. Apply Pareto optimality theory to longitudinal blood samples
from newborn children profiled by mass cytometry to understand immune
phenotypic trade-offs and their mechanisms describing how the immune sys-
tem adapts to environmental influences early in life.
Paper IV. To study the transcriptional variation of human immune re-
sponses to bacterial and viral challenges in Primary Immunodeficiency Dis-
order (PID) patients.
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Chapter 5
Methods
5.1 Study designs
The data contained in this thesis are collected from different cohorts. Re-
spective ethical committees have approved the studies protocol and written
informed consent has been obtained from all participants except for the used
data from a public repository.
5.1.1 Paper I
Paper I is based on data of 1575 healthy individuals across multiple cohorts:
sampled 1) at the Stanford University clinical trials unit, 2) in the United
Kingdom [151], and 3) in Belgium [85]. They consist of men and women be-
tween 8 and 89 years of age. Among the participants were twin subjects. All
three cohorts measured the frequencies of various immune cell populations
in samples of peripheral blood mononuclear cells. Moreover, a diverse set of
functional responses (168 signaling responses to cytokine stimulations and
vaccination to five influenza strains) was measured in the Stanford cohort.
5.1.2 Paper II and III
Paper II& III are based on the TELLUS cohort of human newborns and their
respective parents’ blood samples collected longitudinally at the Karolinska
University Hospital at delivery (from the umbilical cord), and during week
1, and 40 (from peripheral blood). The cohort consists of very preterm chil-
dren (< 30 weeks of gestational at birth) and term children (>= 37 weeks
of gestational age at birth).
In Paper II, we assessed antibodies against 93,904 epitopes from 206 viruses
in 32 preterm and 46 term mother-child pairs. We compared detected anti-
bodies in both children groups as well as within mother-child dyads. Also,
15
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we performed multiplex ELISA assays to quantify IgG specific to known
immunodominant epitopes from five common viruses.
In Paper III, we have analyzed blood samples collected longitudinally from
15 newborns of TELLUS cohort. The cells were analyzed using single-cell
mass cytometry resulting in the antibody-detected expression of 38 proteins
in thousands of cells. 22 and 14 markers were selected to precisely focus the
analysis of B and Cluster of Differentiation (CD)4+ T cells, respectively.
5.1.3 Paper IV
Paper IV is based on the generated bacterial and viral-induced immune tran-
scriptional profiles from PID cohort. It is an ongoing study and consists of
around 20 patients with different immunodeficiency disorders undergoing
treatment at the Karolinska University Hospital. We compared the results
of PID patients with healthy individuals.
5.2 Experimental methods
In this section, I’m introducing the working principles of the main exper-
imental methods used to generate the data presented in this thesis. We
have employed methods capturing cellular components behaviors at differ-
ent length scales.
5.2.1 Mass cytometry
Mass Cytometry or Cytometry by Time Of Flight (CyTOF) is a mass spectrometry-
based technique for high-throughput measurements of protein abundances
with single-cell level resolution [60, 62, 152]. It is a variation of flow cytom-
etry in which antibodies are labeled with heavy metal isotopes rather than
fluorochromes.
Cells in suspension are stained with antibodies bound with a metal isotope
and are nebulized one by one (Figure 5.1). The spray is evaporated, and the
cells are ionized in argon plasma. The ionized isotopes are passed through
an electric field that accelerates the charged ions and allow filtering away
naturally abundant ions with a low mass that would be otherwise noise to the
signal. The purified isotopes are detected, and a time-of-flight spectrometry
quantifies the ion abundance. The ion abundance is directly related to the
expression levels of the proteins that are bound to the antibodies. Also, this
allows for the combination of up to 40 antibodies without between channels.
Mass cytometry provides a highly multiplexed method for profiling single
cells. In immunology, it is commonly used for cellular phenotypic profiling
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Figure 5.1: Schematic workflow of single-cell analysis in a mass cytometry. Figure reproduced
from [152] with permissions from Elsevier (license number: 4782520495083)
and functional analysis. However, mass cytometry as an antibody-based
method does not support comprehensive profiling of the cells, but instead, it
is limited to a pre-defined set of proteins for which probes such as monoclonal
antibodies exist [63].
5.2.2 mRNA sequencing
mRNA sequencing is a Deoxyribonucleic Acid (DNA) sequencing-based
technology for the high-throughput analysis of the abundance of all mRNA
transcripts existing inside cells. It enables identifying expressed genes and
quantifying their abundances, which are indicative of the phenotype and
functions of cells.
To get mRNA content in a population of cells, cell membranes are bro-
ken in a process called cell lysis, and the cellular contents are released and
stabilized. From the captured mRNA transcripts, gene expression to these
transcripts can be inferred. Given the current sequencing technology, the
extracted mRNA is converted into complementary Deoxyribonucleic Acid
(cDNA) and is linearly amplified through polymerase chain reaction to en-
sure a sufficient amount of material for a robust sequencing. The resulting
cDNA materials are subjected to DNA sequencing. Subsequently, reads are
aligned to the human reference transcriptome, and the number of reads from
each gene determines the abundances of mRNA molecules.
5.2.3 VirScan
VirScan is a phage display method that enables human virome-wide of im-
mune responses at the epitope level [69]. VirScan assay is based on the
immunoprecipitation of antibody-targeted bacteriophages from a library of
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around 94,000 56-amino acid peptides representing the entire proteomes of
1000 viral strains from all 206 viruses known to infect human cells.
Initially, the phage library and plasma containing antibodies are incubated
together, and antibodies bind to the peptides expressed on the surface of the
bacteriophages. Then, antibody-phage complexes are precipitated to mag-
netic beads. Furthermore, the antibody-bead complexes are washed in dis-
tilled water, and heating at a high temperature lyses the phages. The region
coding for the clonally expressed peptide is amplified through polymerase
chain reaction run and subjected to massive parallel DNA sequencing. To
identify the targeted peptides, the reads are mapped to the reference viral
library, and the read counts for each peptide.
5.3 Computational methods
5.3.1 Multivariate features selection
Most of the technological development in recent year aims at measuring mul-
tiple parameters in a given sample. These could be protein, gene expressions
or immune cell frequencies.
Suppose that we are interested in understanding how an individual’s im-
mune system would respond to a stimulus. Given a cohort of N size, we will
collect functional or transcriptional responses, {y1, . . . , yN}, to stimuli. At
the same time, we will measure immune cell population frequencies or gene
expressions in all individuals in the cohort, X. Then, from here, we need to
describe the inevitable interindividual variation in the response, y. We can
assume that only a fraction of the variables or predictors in X explain the
variation in the response, y (renormalization theory).
To this end, Partial Least Squares (PLS) [153] regression is used to relate the
immune cell compositions or gene expressions of individuals with functional
responses to stimuli. Linear model assumes that the response and predictors
are related through the functional form
yˆ = Xβ (5.1)
Where, y is a vector, yˆ is the predicted response, X is a matrix of predic-
tors, and β is the coefficient vector for functional response. PLS finds a
set of linear combinations of cells populations that are strongly correlated
with the functional response. PLS carry out feature selection as a group by
maximizing the covariance between X and y.
max
β
cov(X, y) (5.2)
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Indeed, a set of collective variables is chosen so that individuals with similar
coordinates in the space drawn by these collective variables respond similarly
to stimuli.
PLS is a "coarse graining" method that allows investigating the behavior of
immune system as we zoom out and examine the system at different length
scales.
5.3.2 Archetype analysis
As discussed above, the immune system is inherently regulated. It mounts
an immune response against infection and maintains self-tolerance to host
tissues through checkpoints [154, 155]. This is observed on the well-regulated
structure of the immune phenotype space from single-cell data that results
in a specific geometrical shape. In addition, single cells can exist in discrete
groups and/or in a continuum when cells are under cell differentiation pro-
cess.
Archetype analysis is an unsupervised approach based on an evolutionary
tradeoffs theory to learn the geometrical shape of proteins or gene expres-
sion space [156]. The theory suggests that cells that need to perform multi-
ple tasks, their performance levels cannot be concurrently optimized for all
tasks, and hence the competition between them affects phenotype selection.
As a result, cells grow and differentiate themselves with respect to the en-
vironment through a precise trade-off. To this end, the concept of Pareto
optimality has been used [156–159]. As a result, cells are arranged in convex
geometrical objects or polytopes like line, triangle, tetrahedron, etc. The
vertices, called archetypes, of these structures are the extreme protein ex-
pression profiles optimal for each task.
Identifying archetypes. How do we find these geometrical structures? We
identify first the archetypes of a polytope best-fitting convex hull of the
data in protein expression space by using Principal Convex Hull Analysis
(PCHA) algorithm [160]. The goal of the algorithm is to find the best-fit
polytope whose vertices, archetypes, are on the convex hull of the data. To
do this, the algorithm needs to meet two conditions.
First, the vertices are expressed as a weighted average (convex combination)
of the data points. This is to make sure that the archetypes are the rep-
resentatives of the protein expressions space. Suppose that we are given N
cells withM measured protein surface markers {x1, ..., xN}, where xi ∈ RM .
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Each archetype can be expressed as a convex combination of all cells,
zj =
N∑
i=1
cijxi (5.3)
where cij are the convex coefficient, 0 ≤ cij ≤ 1,
∑N
i=1 cij = 1 and j = 1, ..., k
for k archetypes. For a set of archetypes, their representation could be
written as follows
Z = XC (5.4)
where X ∈ RM×N is the data point matrix, C ∈ RN×k is the coefficient
matrix and Z ∈ RM×k is the matrix of archetypes.
Second, the archetypes need to be on or near the convex hull of the data.
Approximating the data points by a weighted average of the archetypes does
this. Given k archetypes {z1, ..., zk}, where kj ∈ RM , each cell is expressed
as
xi =
k∑
j=1
sjizj (5.5)
where sij are the convex coefficient, 0 ≤ sji ≤ 1, and
∑N
i=1 sji = 1. For all
cells, X˜ = ZS = XCS, where S ∈ Rk×N is the matrix of sji coefficients.
The algorithm is constrained to optimize both criteria. Given that it aims to
approximate the data points from the archetypes, the optimization problem
consists of minimizing the difference between original and is solved using a
projected gradient descent on a constrained space:
argmin
c,s
‖X −XCS‖2 (5.6)
From here, the number of archetypes that describes the data is determined.
To do this, PCHA computed the explained variance [159, 161, 162] for each
number of archetypes k = 2, ..., kmax as follows
EV =
1
N
N∑
N=1
(1− |pn − sn||pn| ) (5.7)
Where pn is the nth data point from N points and sn is the closest point
to pn in the found polytope. Therefore, an optimal number of archetype
k∗ is identified when increasing number of archetypes does not significantly
increase EV . As a result, optimized set of archetypes of a polytope that
best encompasses the data is obtained using the Sisal [163] algorithm, which
is less sensitive to outliers.
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Characterization of a continuum of cell states in the presence of multi-
tasks inside a polytope. After finding a polytope that best fit our data
(convex regions), we need to explore the concavity region in the middle of
the polytope [164].
Multiple tasks are characterized by performance functions of cells working
together to provide a function within a differentiated cell type [164]. The
overall performance was defined as a sum of contributions of individuals cells,
j = 1, . . . , N to each of tasks, i = 1, . . . , k. The vector Mj is the protein
expression of cell j. The performance of cell j in task i, Pi(Mj), is partially
defined by its protein expression profile. In addition, with longitudinal data,
a continuum of cell state can arise when tasks have spatiotemporal perfor-
mance gradients. The movement of cells in the protein expression space over
time, especially in newborn children, confirms this.
To incorporate this gradient effect in our definition of performance of cell j,
a mutlitplicative factor φi(tj) is added for each task i.
Therefore, the total performance is an increasing function of the sum of all
cells performance in the k tasks and can be written as:
F = f(S1, ..., Sk) (5.8)
Si =
N∑
j=1
φi(tj)Pi(Mj) (5.9)
In order to represent the tasks dependence on protein expression gradients,
we used linear performance gradients for tasks at archetype 1 and 2, no
gradient at archetype 3, for B-cells for example. this movement of cells
with respect to archetypes canbe emulated as φ1(t) = x, φ2(t) = 0.5 − x,
and φ3(t) = 1. Where x is the spatiotemporal position of cells. Moreover,
a simple linear performance function that decays linearly with Euclidean
distance dij from the archetype is used Pi = B− dij , where B is a constant.
The derivative of F with respect to M leads to the solution
0 =
dF
dM
=
k∑
i=1
φi(tj)
∂f
∂Si
∂Si
∂Mj
=
k∑
i=1
φi(tj)
∂f
∂Si
∂Pi
∂dij
∂dij
∂Mj
(5.10)
The solution would show that cells lie along a continuum range of expression
in protein expression space inside polytope, whose vertices are the maxima
of the performance M∗. The performance gradients φ(t) describe cell spe-
cialization pattern to tasks that suggests a pseudo-time trajectories in the
developmental path from single-cells data.
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Archetype analysis enables studying changes to the phenotypic space induced
by perturbations in the system. I used this method to understand human
newborns lymphocyte development.
5.3.3 Serological data analysis
Virscan
Experimentally, the input consists of three types: the phage-only or ’input,
the beads-alone or background, and the sample. The latter is treated in
duplicates for validation purpose. The reads from all inputs are aligned sep-
arately to the reference viral genome and counted reads for each epitope.
The output reads counts of the ’input’ serves as a null model and a zero-
inflated generalized Poisson distribution describes it.
For each sample duplicate, the output reads count is fit a Poisson model
and solve for the coefficients of the parameters as function the ’input’ read
count. Based on this comparison, p-values are calculated for significance of
each epitope’s enrichment. An epitope is called a hit, if the -log(p-value)
is greater than a threshold, 2.3. Hits found in the background of the assay
were masked in the hits found in sample. Lastly, number of unique hits per
viral species makes up a virus score, so-called VirScore.
Statistical model of antibody kinetics
We were interested in determining antibody levels in children and their moth-
ers. Total IgG was measured with an ELISA assay in all longitudinal serum
samples. To capture the kinetics of passively acquired maternal antibodies
against certain viruses, we used a stochastic model [165]. For each individual,
log-transformed levels of antibody, x, at a particular age, a, are described
by a normal distribution with age-dependent mean m(a) and standard de-
viation, s.
x ∼ N(m(a), s2) (5.11)
The log-transformed levels of maternal antibodies decay linearly with age
and with a decay rate, d, from ln(m0 + b) for low ages, and approaches a
detectable level of antibody, b, for higher ages. The mean log-transformed
level of maternal antiviral antibodies varies with age
m(a) = ln(m0e
−da + b) (5.12)
We used the maximum likelihood estimation to regress the parametersm, b, d
and s. We also computed the half-time, ln(2)/d, and the mean-life, 1/d, of
antibody.
Chapter 6
Results and discussion
In this chapter, the main findings contained in the appended papers are
presented and discussed. The first section is based on the attached paper
I, and results from understanding inter-individual variation in immune cell
composition and their responses to cytokine stimulations. In the second
section, which is based on paper II, a global analysis of maternal antibodies
to all viruses in newborns is presented. In the third section, an analysis of
phenotypic trade-offs and their mechanisms using Pareto optimality (Paper
III) is displayed. Finally, a transcriptional method aiming at understanding
immune defects in patients with primary immunodeficiencies (Paper IV) is
discussed.
6.1 Paper I: Continuous immunotypes describe hu-
man immune variation and predict diverse re-
sponses
6.1.1 Introduction
The relative immune cells frequencies in blood in the human population
can vary extensively between individuals, and the differences are poorly un-
derstood. Surprisingly, these variations do not seem to have a substantial
impact on immune fitness.
We hypothesized that for the immune system to exhibit such flexibility, indi-
vidual cells have to be able to tune their response to stimulation in relation
to the levels of other immune cells. This is similar to quorum sensing in
bacteria, where collective behaviors like biofilm formation and sporulation
emerge from interactions and signals between bacteria.
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6.1.2 Results
In this paper, the aim was to investigate whether differences in immune
response could be explained by variation in immune cell compositions across
individuals.
To do this, we analyzed the frequencies of various immune cell populations
and their responses in samples of peripheral blood mononuclear cells from
1575 healthy individuals across multiple cohorts.
Figure 6.1: Principal component analysis of immune cell composition. a) Projection of high dimen-
sional immune cell composition onto the two principal components for Stanford, Reorderer, and Carr
cohorts. b) Displaying individuals with extreme values of specific immune cell populations on the top
two PCs of global immune cell composition data from Stanford cohort.
The main finding of the study is that the inter-individual differences in im-
mune cell composition are continuously distributed rather than clustering in
discrete groups with similar immune cell composition (Figure 6.1a). Next,
we show that individuals with extreme outlier values of specific cell type
frequencies are not outliers with respect to their collective immune cell com-
position (Figure 6.1b).
Similarly, individuals with extreme values (considered outliers) in individual
immune cell populations (CD4/CD8 ratio, Monocytes, and NK cells) are not
outliers using a collective description via PCs (Figure 6.2). Thus, to define
individuals with outlier phenotypes, collective states of their immune cell
composition can be helpful.
To this end, a conceptual framework for the analysis of measured frequencies
of various immune cell populations in healthy humans and their responses
to diverse cytokine stimulation is devised. We sought to know a small set
of linear combinations of specific immune cell frequencies that could predict
individual immune responses to stimuli. To this end, PLS method identified
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Figure 6.2: Overlaying the top (red) and bottom (blue) 5% of the CD4/CD8 ratio, monocytes, and NK
cells onto the distributions of PC scores across the Stanford cohort.
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Figure 6.3: Linear regression model analysis. Plotting model error as function of number of variables
(e.g latent variables and PCs) represent learning curves for PLS and Principal Component regression
(PCR) models: with a) normalized, and b) raw error. c-d) Displaying the mean and interval of signatures
of the top three latent variables across all responses.
a set of three variables of individual immune cell frequencies that robustly
predict diverse functional responses in healthy individuals (Figure 6.3). This
set of aggregate immunological variables defines an individual’s immunotype.
Figure 6.4: Projection of individuals in the immunospace defined by the top three latent variables. The
color code reprents gradient of age, and the red line is an immunological age axis. b) Distribution of
interindividual Euclidean distances in the immunospace spaned by the first 3 LVs for different discrete
age groups. c)Immunological age axis defined by regression coefficient of immune cell populations.
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To better understand human immune variation, we analyzed the distribution
of individuals’ immunotypes displayed in the space defined by the top three
PLS components, see figure 6.4. We find that even though inter-individual
differences in specific cell population frequencies can be significant, unre-
lated individuals of younger age have more homogeneous immunotypes than
older individuals. Increasing heterogeneity of immunotypes in old individuals
shows the diversification of immune cell composition with age. It indicates
the effects of diverse cumulative environmental influences on an individual’s
immune system over time.
Figure 6.5: Distributions of positions of individuals to the line of age axis are compared between HCMV
seronegative and seropositive individuals for young and old.
Finally, we sought to understand how Human Cytomegalovirus (CMV)
serostatus shapes the human immune system. To do this, we projected
individuals’ immune cell composition onto the age axis, a line that best
correlates with age in space defined by top three PLS components. By an-
alyzing the distribution of individual’s cell populations projected onto the
line (Figure 6.4a), we found that the human CMV seropositivity was rep-
resented by a change in immunotype. Across age groups, the distribution
of cytomegalovirus seropositive individuals is shifted upward along the age
axis (Figure 6.5), and displayed immunotype similar of older individuals.
6.2 Paper II: The repertoire of maternal anti-viral an-
tibodies in human newborns
6.2.1 Introduction
Maternal antiviral Antibodies (mavAb) provide neonates with primary pro-
tection against viral infections early in life. However, little is known about
the global repertoire of transferredmavAb IgG, its variation in children, the
epitopes targeted, and its duration after birth remains poorly defined. To
fill this gap, we have collected samples from very preterm and term newborn
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children at birth and during weeks 1, 4, and 12 of life.
In this study, we assess maternal antibodies against 93,904 epitopes from 206
viruses (except zika and corona COVID-19 viruses) known to infect human
cells in 78 mother-child dyads.
6.2.2 Results
In this paper, we assessed maternal antiviral antibodies in preterm and term
mother-child pairs using VirScan [69] method. The method output is defined
as a number of peptide hits that do not share epitopes, called VirScore.
Figure 6.6: The repertoire of maternal antiviral antibodies. Top 44 viruses most commonly targeted by
maternal antibodies in preterm (<30 gestational week) and term (>37 gestational week) children. The
color code box at the bottom indicates time point, either at birth or day 2-3, when the first available
sample for each child was collected.
We investigated the global repertoires of maternal antibodies to viruses in
samples collected at birth or first sample taken in the first week of life in
term and preterm children. Surprisingly, we found that term and preterm
children received similar repertoire of maternal IgG. This suggests that the
transfer of maternal antibodies happen before 24 weeks of gestation. The
most commonly target antibodies in newborn children is similar to the par-
ents, and they are CMV, Herpes Simplex Virus (HSV), Epstein-Barr virus
(EBV), rhinovirus A, and adenovirus C, see Figure 6.6.
To gain a deeper insight into the determinant of protective immunity, we
investigated antibody specificity on an epitope level. First, we found a lin-
ear relationship between the number of epitopes targeted by maternal anti-
bodies and the genome size (Figure 6.7a), suggesting that virus with large
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Figure 6.7: a) Viral genome size linearly correlates with the number of epitopes targeted by maternal
antibodies. b) IgG antibodies in mother (top) and children (bottom) more often targets similar peptides
of RS-virus major surface glycoprotein G. c) All epitopes targeted in seropositive newborn children
show immunodominant epitopes (> 50% of seropositive)
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genome size have many epitopes that are recognized by antibodies. Sec-
ond, we wanted to know if there exists epitopes that are preferably targeted
during an immune response in the repertoire of maternal IgG, called immun-
odominant epitopes. For example, in both mother and children, antibodies
targeted more often an epitope located in 141-224 amino acid region of Res-
piratory Syncytial (RS)-virus major surface glycoprotein G (Figure 6.7b).
Lastly, we displayed the epitopes as a percentage of seropositive children in
all viruses commonly targeted by maternal antibodies in newborn children
(Figure 6.7c). The number immunodominant epitopes (epitopes targeted by
> 50% of seropositive children) varied from virus to virus. These epitopes
have implication in developing vaccine.
Figure 6.8: Factors determining maternal antibody concentrations. Pearson’s correlation between
antibody concentrations profiled by ELISA in mothers and their children a) CMV, b) EBV, and c) RS-
virus. d) Variance in IgG newborn IgG concentration is explained by birth weight, gestational age,
maternal antibody concentration, as well as the unknown or residuals.
Although a correlation of 0.5 is found between the concentration of antibodies
and VirScan VirScores output, we quantified antibody levels in CMV, EBV,
and RS-virus using enzyme-linked immunosorbent (ELISA) assay. Term chil-
dren have antibodies with higher IgG concentrations than preterm children
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(Figure 6.7a-c). Maternal IgG concentration was the most determinant fac-
tor of IgG concentration in newborns for CMV, and EBV; while gestational
age influenced the IgG concentration for RS-virus (Figure 6.7d). The differ-
ences in determinant factors suggest that placental antibody transfer follows
different rules.
CMV EBV RSV HSV-1 IA
Pre Term Pre Term Pre Term Pre Term Pre Term
t1/2 47.8 48 54.9 84.5 66.3 81.6 51.8 74.3 65.4 78
t 67.4 69.3 79.1 121.9 95.3 117.8 74.7 107.2 94.5 112.6
Table 6.1: Antibody life span (halftime, t1/2(days), and lifetime, t(days))
We studied the duration of conferred protection by maternal antibodies in
children. Maternal antibodies last 2-3.5 months (Table 6.1) on average and
premature infants loose their antibodies much faster than full term children
due to their lower concentrations transferred at the time of birth. Given that
it has been reported that maternal antibodies interfere with vaccines, this
finding could be helpful in vaccine scheduling in newborn children.
6.3 Paper III: Analyses of phenotypic trade-offs to
understand human lymphocyte development
6.3.1 Introduction
In multicellular organisms like the immune system, individual cells face a
dilemma. No cell can be optimally suited for all possible tasks, and therefore
cells specialize to perform specific tasks. For example, in the human immune
system, cytotoxic lymphocyte kills virus-infected cells, and B-lymphocytes
produce antibodies, etc. That way, a range of phenotypic variants found in
a system can be explained regarding of trade-offs between specialist pheno-
types and more generalist phenotypes. There is a need for describing such
phenotypic trade-offs from high dimensional single-cell data.
We have applied the Pareto optimality theory (162) to longitudinal blood
samples from newborn children analyzed by mass cytometry to describe how
the immune system adapts to environmental influences early in life.
6.3.2 Results
In this paper, the goal was to understand immune phenotypic trade-offs and
their mechanisms describing how the immune system adapts to environmen-
tal influences early in life. To do this, we applied Pareto optimality theory
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to learn geometrical shapes of B and CD4+ T cells protein expression space.
days of life
1
2
159
Figure 6.9: B cell protein expressions plotted
in the top two principal components space are
bounded by a triangle.
arch.1 arch. 2 arch. 3
markers CD9 CD39
CD38 CD22
CD24 CD44
CD29 IgD
CD20 CD99
CD7 CD7
CD49d HLA-DR
CD27 CD19
CD45RA CD45RA
CD5 CD29
HLA-ABC HLA-ABC
CD20
CD49d
cell subsets Naïve IgD+ memory
time point Day 1 Day 159
Table 6.2: Enriched markers, cell subsets, and time
point at each archetype in triangle B cells
We wanted to understand whether cells formed well-separated clusters of
cells with similar protein expression profiles. The single-cell data showed an
elongated cloud of phenotypes with expression gradients. Cell phenotypes
of the first available sample in each child were different from phenotypes
of samples from later time points. This indicates that there are changing
phenotypes of individual cell populations over time. Then, we sought to
understand whether cells fall in a low-dimensional polytope. Towards this
end, we fitted the data to polyhedral with 3-7 vertices and assessed their
statistical significance. We found that neonates B and CD4+ T cells protein
expression spaces are best represented by a triangle (figure 6.9) and a non-
linear 4D simplex (figure 6.10), respectively.
1
2
159
days of life
Figure 6.10: CD4+ T cell
protein expressions projected
in the low dimensional space
spanned by top three PCs are
best represented by a non-
linear 4D simplex.
arch.1 arch. 2 arch. 3 arch. 4 arch. 5
markers CD29 CD38 CD45RA
CD161 CD5 CD38
CD44 CD45 CD44
HLA-DR CD3e CD4
CD5 CD29
CD4 CD29
CD45 CD5
CD127
CD27
CD9
CD7
CD45
CD3e
cell subsets Naïve Naïve central effector Naïve
time point Day 1 Day 2 day1/159 day 2 day 1/159
Table 6.3: Enriched markers, cell subsets, and time point at each
archetype in pentahedron CD4+ T cells
The vertices, called archetypes, correspond to extreme protein expression
profiles optimal for specific tasks. To infer tasks or functions, we tested the
enrichment of markers as function of Euclidean distance from each archetype,
and retained markers that are maximally expressed in the cells closest to each
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archetype. Archetypes correspond to major cell subset with a set of markers,
except archetype with closest cells that display homogeneous protein expres-
sions (Table 6.2&6.3).
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Figure 6.11: A continuum pattern of adaptive protein expressions describe specialization of cells to
tasks in a triangle B cells.
Next, we sought to know the adaptive protein-expression continuum and
how it corresponds to the specialization of cells to tasks overtime. We found
that B cells lie along a continuum range of expression in protein expression
space inside the triangle. Specifically, 1D continuum patterns of adaptive
protein-expression describe specialization of cells to tasks and infer pseudo-
time trajectories in the developmental path of B cells. This suggests that
there are many temporal paths with different ordering to tasks, rather than
one temporal path to differentiation.
6.4 Paper IV: A transcriptional method to understand
functional defects in patients with primary im-
munodeficiencies
6.4.1 Introduction
PID is a heterogeneous group of disorders that may lead to faulty innate
and adaptive immune system. In many PID patients, the immune response
is insufficient to eliminate specific pathogens, which leads to an increased
susceptibility to infections and autoimmunity in this group of patients. A
challenge remains in the diagnosis and treatment of PIDs due to variable
symptoms dependent on the underlying immune system defects.
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We developed a transcriptional method based on whole blood stimulated
with Bacillus Calmette-Guérin (BCG),Lipopolysaccharidea (LPS), and In-
fluenza A virus (IAV) to better understand functional defects in 11 PID
patients. mRNA sequencing technique analyzes the induced transcriptional
programs.
6.4.2 Results
In this work, we aimed to study transcriptional variation of human immune
responses to bacterial and viral challenges in primary immunodeficiency dis-
order (PID) patients. We particularly wanted to compare transcriptional
Figure 6.12: Transcriptional responses to microbial antigens are different between PID patients and
similar in healthy controls. We used PCA to project high dimensional immune gene expression profiles
defined as a ratio between stimulated and non-stimulated states.
responses to microbial pathogens between healthy individuals and PID pa-
tients. We asked whether there is an overlap of transcriptional responses in
PID patients and healthy controls. Immune stimulations induced transcrip-
tional responses that clustered in discrete groups of healthy individuals with
a similar response to a specific stimulant antigen and formed unclear clusters
for PID patients irrespective of the antigen. We conclude that transcriptional
responses to specific microbial antigens are different in PID patients and sim-
ilar in healthy individuals.
Given that the transcriptional responses to specific antigen are sparsely dis-
tributed among PID patients, we asked whether there is a collective set of
genes that could predict the variation of responses among patients. Towards
this end, Partial Least Square Discriminant Analysis (PLS-DA) defined a
set of linear combinations of the genes known as PLS components, termed
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Figure 6.13: Three key combinations of gene expression profiles predict variation of transcriptional
responses to microbial challenges in PIDs patients. A) Classification error rate suggests an optimal
number of predictive components to be 3. B) PIDs patients plotted in the low dimensional space
defined by the first three LVs. c-e) Top 20 genes contributing the most to the first top 3 LVs, color coded
by a stimulation type with the maximal expression levels.
Latent Variable (LV). By projecting individual PID patients in the low-
dimensional LVs, patients with similar response to specific immune stimula-
tion form clear clusters.
Finally, we compared each PID patient with healthy controls to identify gene
variants associated with transcriptional responses to prototypical stimula-
tions. Given the heterogeneity of identified gene variants across patients, we
selected top 40 genes contributing to each of the top 3 LVs for visualization
purpose (Figure 6.14). This allows assessing and understanding functional
defects in PID patients.
6.5 Discussions
In this thesis, a systems approach is used to characterize human immune
system behaviors as probed in different experiments with a focus on eluci-
dating environmental influences. How closer are we in providing a conclusive
description of organized behaviors observed in the human immune system?
To perform its protective function and preventing immunopathology, the im-
mune system involves coordinated action of many components of the system.
The challenge here is to select a simple representation for the elementary in-
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Influenza A virus (IAV) Bacillus Calmette–Guérin (BCG) Lipopolysaccharidea (LPS)A B C
Figure 6.14: Comparison of gene expression profiles between healthy controls and PID patients. The
statistical test shows the statistical significance levels of enrichment by -log10(Pvalue).
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teractions that could determine the obtained immunological observables. For
example, to mount an immune response, cooperativity of multiple immune
cell populations provides inhibitory and stimulatory feedback. The use of
such simple model of the immune system alleviates our lack of knowledge
of most of the rules for immune cells interdependence. Indeed, such missing
knowledge could be found in the literature. However, in many cases, studies
are performed under different experimental conditions or answer different
questions, hence a need to standardize assays [166, 167]. As a result, math-
ematical methods that establish which components are more relevant than
others in giving rise to a given immune system behavior are used.
Our findings presented in this thesis have proven that immunology can ben-
efit from a global view of the immune system. We have shown that a set
of collective individual immune cell population can predict a healthy indi-
vidual’s immune response to stimulation. Also, we have identified a set of
linear combination of gene expression profiles that predict variation of tran-
scriptional responses to microbial stimulants in PID patients.
A possible criticism of the results we present here is that our results depend
on measurements done on cohorts of particular individuals. Given the differ-
ences in genetics, environmental exposures, lifestyle, and immune phenotype
in human populations worldwide, it would be interesting to carry out similar
studies on independent cohorts from different geographical locations with
similar or additional parameters measurement. For example, assessing ma-
ternal antiviral antibodies in children born in Africa or Asia could validate
further our findings.
Chapter 7
Conclusions
In this section, I’m outlining the new results obtained during the course of
this thesis.
• The human immune variation is continuous, and not described by dis-
crete groups of individuals with similar immune cell populations. A set
of aggregate immune cell population frequencies can define an individ-
ual’s immunotype, and robustly predict diverse functional responses to
cytokine stimulations. Although inter-individual variations in specific
cell population frequencies can be large, older individuals have, by far,
more heterogeneous immunotypes than younger individuals.
• The global repertoire of maternal antibodies target about 5-10 differ-
ent viruses, and the transferred antibodies mirrors those found in the
mothers. To our surprise, the repertoires of maternal antibodies are
similar between very preterm children born before 30 weeks gestation
and term children born after 37 weeks gestation. Also, the functional
capability of antibodies was comparable until around three months of
age. However, the concentrations of antibodies at birth are lower in
preterm than in term children. The conferred protection by maternal
antibodies lasts 2-3.5 months on average, and premature infants loose
their antibodies much faster than full term children due to their lower
concentrations transferred at the time of birth.
• We learned geometrical shapes of protein expression space of devel-
oping human newborn lymphocyte in early life. Single B cells are
arranged in a triangle, while CD4+ T cells are best represented by
pentahedron. The vertices of these structures are extreme protein ex-
pression profiles optimal for tasks and correspond to major cell subsets.
Cells lie along a continuum of expression inside polytope. In triangle B
cells, a 1D continuum of states describes cell specialization pattern to
tasks and suggests pseudo-time trajectories in the developmental path
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of newborn B cells.
• The variation of transcriptional responses to microbial stimulants is
large among PID patients, and low in healthy individuals. Our results
show that three combinations of a collective set of gene expression pro-
files can explain the differences in transcriptional responses to stimuli
from PID patients. We identified gene variants associated with the dif-
ferences in transcriptional responses to microbial stimulants between
PID patients and healthy individuals allowing understanding immune
functional defects in patients.
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